Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (51-60 of 542) with videos related to

Pageof 55
Sort By:
Antimicrobial Agents and Chemotherapy|May 1, 1974
Antileishmanial effect of allopurinolM A Pfaller, J J Marr
Infectious Disease Clinics of North America|January 10, 2002
Antifungal susceptibility testing. New technology and clinical applicationsM A Pfaller, W L Yu
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 20, 2003
Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum beta-lactamase in EuropeR N Jones, M A Pfaller,
The Journal of Hospital Infection|June 1, 1991
Feasible and desirable future targets for reducing the costs of hospital infectionsR P Wenzel, M A Pfaller
Diagnostic Microbiology and Infectious Disease|December 24, 1997
Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacinM A Pfaller, R N Jones
Journal of Clinical Microbiology|February 24, 2001
Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999)R N Jones, M A Pfaller
The American Journal of Tropical Medicine and Hygiene|July 1, 1983
Oxygen enhances the antimalarial activity of the imidazolesM A Pfaller, D J Krogstad
Diagnostic Microbiology and Infectious Disease|June 23, 1998
Bacterial resistance: a worldwide problemR N Jones, M A Pfaller
Journal of Clinical Microbiology|June 29, 2012
Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012M A Pfaller, D J Diekema
Diagnostic Microbiology and Infectious Disease|January 1, 1990
Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicansM A Pfaller, J Riley, T Koerner
Pageof 55

Showing results (51-60 of 542) with videos related to

Sort By:
Pageof 55
Antimicrobial Agents and Chemotherapy|May 1, 1974
Antileishmanial effect of allopurinolM A Pfaller, J J Marr
Infectious Disease Clinics of North America|January 10, 2002
Antifungal susceptibility testing. New technology and clinical applicationsM A Pfaller, W L Yu
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 20, 2003
Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum beta-lactamase in EuropeR N Jones, M A Pfaller,
The Journal of Hospital Infection|June 1, 1991
Feasible and desirable future targets for reducing the costs of hospital infectionsR P Wenzel, M A Pfaller
Diagnostic Microbiology and Infectious Disease|December 24, 1997
Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacinM A Pfaller, R N Jones
Journal of Clinical Microbiology|February 24, 2001
Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999)R N Jones, M A Pfaller
The American Journal of Tropical Medicine and Hygiene|July 1, 1983
Oxygen enhances the antimalarial activity of the imidazolesM A Pfaller, D J Krogstad
Diagnostic Microbiology and Infectious Disease|June 23, 1998
Bacterial resistance: a worldwide problemR N Jones, M A Pfaller
Journal of Clinical Microbiology|June 29, 2012
Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012M A Pfaller, D J Diekema
Diagnostic Microbiology and Infectious Disease|January 1, 1990
Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicansM A Pfaller, J Riley, T Koerner
Pageof 55